Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513069 · ClinicalTrials.gov registry record · NA
Mobile Contingency Management for Smoking Cessation in Returning US Veterans
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 291
- Enrollment target
NCT02513069: Completed NA study, sponsored by Duke University.
NCT02513069 is a NA study that has completed, run by Duke University. The registered enrollment target is 291 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02513069, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 291 participants
- Enrollment target
Study Summary
The primary goal of the study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that the investigators call mobile CM, or mCM, in promoting smoking abstinence in US Veterans. The mCM intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, and smoking cessation medications. The primary aim is to evaluate how effective this intervention is in promoting smoking abstinence compared to telehealth interventions for smoking cessation.
Primary Outcome
Participants' self-report of smoking in the past seven days will be measured at 6-month follow-up study visit.
Interventions
- OTHER Nicotine gum
- BEHAVIORAL Telephone counseling
- BEHAVIORAL mobile contingency management
- OTHER Nicotine patch
- OTHER Nicotine lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-02-14 |
| Phase | NA |
What the finished NCT02513069 record still lists
NCT02513069 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 5 interventions - of which Nicotine gum is the first listed.
NCT02513069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02513069 about?
NCT02513069 is a clinical study titled "Mobile Contingency Management for Smoking Cessation in Returning US Veterans". The primary goal of the study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that the investigators call mobile CM, or mCM, in promoting smoking abstinence in US Veterans. The mCM intervention will combine a mobile system to reward non-smoking...
What is the current status of trial NCT02513069?
This trial is currently completed. It is a NA study. The enrollment target is 291 participants. The study started on 2015-01. Estimated completion is 2019-02-14.
What interventions are being tested in trial NCT02513069?
The interventions under investigation include: Nicotine gum (OTHER), Telephone counseling (BEHAVIORAL), mobile contingency management (BEHAVIORAL), Nicotine patch (OTHER), Nicotine lozenge (OTHER).
Who is sponsoring clinical trial NCT02513069?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02513069's enrollment target sits among peer trials
291 375th of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia